RCKT FY 2017 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$538M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$204,000

Operating Income

-$27M

Net Income

-$29M

EPS (Diluted)

$-4.36

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$102M

Total Liabilities

$54M

Stockholders' Equity

$48M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$204,000	-$169,000	-20.7%
Operating Income	-$27M	-$42M	+36.2%
Net Income	-$29M	-$43M	+31.2%